PSMA PET/MRI can successfully determine the risk of prostate cancer recurrence

Glass laboratory flasks on light table

In men recently diagnosed with intermediate or high-grade prostate cancer, prostate specific membrane antigen (PSMA) PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy.

The COVID XBB.1.5 subvariant is spreading. Here’s what we know.

Previous article

Wordle today: Here’s the answer, hints for January 8

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News